Do Guidelines Preclude Hepatitis B Patients from Receiving Treatment?

被引:6
|
作者
Degertekin, Bulent [1 ]
Lok, Anna S. [1 ]
机构
[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA
关键词
LAMIVUDINE;
D O I
10.1002/hep.22722
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:700 / 701
页数:2
相关论文
共 50 条
  • [31] Treatment of hepatitis B
    Wai, CT
    Lok, ASF
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (10) : 771 - 778
  • [32] Treatment of hepatitis B
    Chun Tao Wai
    Anna S. F. Lok
    Journal of Gastroenterology, 2002, 37 : 771 - 778
  • [33] Treatment for hepatitis B
    Cooke, Graham S.
    Main, Janice
    Thursz, Mark R.
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 : 87 - 91
  • [34] Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment
    Li, Guo-Jun
    Yu, Yi-Qi
    Chen, Shao-Long
    Fan, Ping
    Shao, Ling-Yun
    Chen, Jia-Zhen
    Li, Chang-Shui
    Yi, Bin
    Chen, Wei-Cun
    Xie, Shu-Yuan
    Mao, Xiao-Na
    Zou, He-Hui
    Zhang, Wen-Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4121 - 4128
  • [35] Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
    Chen, Kai-Lin
    Chen, Jie
    Rao, Hui-Lan
    Guo, Ying
    Huang, Hui-Qiang
    Zhang, Liang
    Shao, Jian-Yong
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Zou, De-Hui
    Hu, Li-Yang
    Wirian, Michael Lucas
    Cai, Qing-Qing
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [36] Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in Taiwan
    Lin, Chih-Lang
    Lin, Yi-Lan
    Liang, Kung-Hao
    Chen, Li-Wei
    Chien, Cheng-Hung
    Hu, Ching-Chih
    Huang, Ting-Shuo
    Shyu, Yu-Chiau
    Yeh, Chau-Ting
    Chien, Rong-Nan
    CLINICAL THERAPEUTICS, 2022, 44 (03) : 403 - +
  • [37] THE EFFICACY OF LAMIVUDINE TREATMENT IN NAIVE CHRONIC HEPATITIS B PATIENTS
    Balkan, Ayhan
    Barutcu, Sezgin
    Erdem, Ramazan
    Konduk, Bugra Tolga
    Yildirim, Abdullah Emre
    Gulsen, Murat Taner
    ACTA MEDICA MEDITERRANEA, 2016, 32 (03): : 663 - 667
  • [38] Treatment of hepatitis B e antigen-negative patients
    Hui C.-K.
    Lau G.K.
    Current Treatment Options in Gastroenterology, 2007, 10 (6) : 474 - 482
  • [39] Treatment with peginterferon versus interferon in Chinese patients with hepatitis B
    Yu, Hai-bo
    Liu, En-qi
    Lu, She-min
    Zhao, Si-hai
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (08) : 559 - 564
  • [40] Is telbivudine superior to lamivudine for the treatment of patients with chronic hepatitis B?
    Buti, Maria
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (09): : 494 - 495